Cole Hugh M 4
4 · Jounce Therapeutics, Inc. · Filed Aug 3, 2022
Insider Transaction Report
Form 4
Cole Hugh M
Chief Business Officer
Transactions
- Award
Common Stock
2022-08-01+20,000→ 126,716 total - Award
Stock Option (Right to Buy)
2022-08-01+40,000→ 40,000 totalExercise: $2.97Exp: 2032-08-01→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option will vest quarterly in 16 equal installments following August 1, 2022.